Register information Protection certificate

DE file number : 12 2024 000 035.4 (Status: pending/in force, Query started: May 13, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTProtection certificate
StatusSTPending/in force
21DE file number DAKZ12 2024 000 035.4
UseVZMedicinal products
95Product nameTIEZAdagrasib oder ein pharmazeutisch verträgliches Salz davon
54Title of basic patentTIGZKRAS-G12C-INHIBITOREN
51IPC main classICM
(ICMV)		 C07D 401/06 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 C07D 401/14 (2006.01)
94Start of term of protectionLBNov 15, 2038
22DE application dateDATJun 11, 2024
Date of publication of application for a certificateOTSep 26, 2024
71/73Applicant/ownerINHArray BioPharma Inc., Boulder, CO, US; Mirati Therapeutics, Inc., Princeton, NJ, US
74RepresentativeVTRMewburn Ellis LLP, 80333 München, DE
Address for service Mewburn Ellis LLP, 80333 München, DE
Patent division in charge 44
68DE file number of basic patentGAKZ60 2018 046 262.7
68EP file number of basic patentGEAKZ18 87 9484.6
43Date of first publicationEVTSep 26, 2024
92
92
92
Domestic authorisationGIS
GIN
GIT
Europäische Kommission
EU/1/23/1744
2024-01-05
93
93
93
93
EU authorisationGES
GEC
GEN
GET
Europäische Kommission
EU
EU/1/23/1744
2024-01-05
Date of the first transfer into DPMAregisterEREGTSep 26, 2024
Date of the (most recent) update in DPMAregisterREGTNov 26, 2024
(Show all update days)(Hide all update days)
  • Nov 26, 2024
    • Applicant/owner: changed
    • Procedures: New applicant/owner details, New applicant/owner details, 25.11.2024: new
  • Sep 26, 2024
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Supplementary protection certificate procedure Application for supplementary protection certificate effectively filed Aug 20, 2024 Sep 26, 2024 Details anzeigen
2 New representative details New representative details Aug 20, 2024  Details anzeigen
3 New applicant/owner details New applicant/owner details Nov 25, 2024  Details anzeigen
View procedures Supplementary protection certificate procedure (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTApplication for supplementary protection certificate effectively filed
Date of legal/procedural statusVSTTAug 20, 2024
Issue numberHN39
YearPJ2024
Publication dateVTSep 26, 2024
Type of publicationPARTBibliographic data
PartHTPart 7
68DE file number of basic patentGAKZ60 2018 046 262.7
68EP file number of basic patentGEAKZ18 87 9484.6
Date of update of the procedureREGTSep 26, 2024
View procedures New representative details (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTNew representative details
Legal/procedural statusVSTNew representative details
Date of legal/procedural statusVSTTAug 20, 2024
74RepresentativeVTRMewburn Ellis LLP, 80333 München, DE
74Previous representativeVTRFWolter, Thomas, Dipl.-Chem. Dipl.-Biol. Dr., 80333 München, DE
Date of update of the procedureREGTSep 26, 2024
View procedures New applicant/owner details (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTNov 25, 2024
71/73Applicant/ownerINHArray BioPharma Inc., Boulder, CO, US; Mirati Therapeutics, Inc., Princeton, NJ, US
71/73Previous applicant/ownerINHFArray Biopharma Inc., 80301 Boulder, CO, US, MIRATI THERAPEUTICS, INC., 92121 San Diego, US
Date of update of the procedureREGTNov 26, 2024